Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin receives FDA approval for generic Atovaquone Oral Solution USP
Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic version of GlaxoSmithKline LLC’s Mepron Oral Suspension, 750…
Lupin ‘Learn and Earn’ programme to train 1,000 graduates by 2020
The company organises convocation for graduates in Panaji
Flying it for pharma
The air cargo industry needs to up its game by ensuring reliability and safety across the supply chain to leverage the growth…
DRL launches muscle disease drug in US
The company's product is the generic version of Bloxiverz Injection
Global Interstitial Cystitis, Bladder Pain Society concludes 3rd annual scientific conference
The objective was to strengthen the existing working principles and take the plunge to innovative steps in the management of…
Over 9500 visitors attend India Lab expo, analytica Anacon India and Pharma Pro&Pack expo 2018
There were around 261 exhibitors from India and overseas at the trade fair trio
Health Ministry prohibits manufacture or distribution for human use of 328 FDCs
The Drugs Technical Advisory Board recommended, amongst other things, that these FDCs may involve risk to human beings
Green ChemisTree Foundation, GCIPR to organise technical conference
The objective of the conference is to enable greater business value for Indian pharma API and bulk intermediate manufacturers
Sun Pharma’s Mohali plant on FDA radar
Recently, the USFDA had issued Form 483 with six observations after an inspection of the company's Halol facility in Gujarat
Zydus Cadila gets tentative nod from USFDA for diabetes drug
The company has received tentative approval from the USFDA for Sitagliptin tablets in strengths of 25 mg, 50 mg, and 100 mg, Zydus…